John P. Saharek - Feb 19, 2022 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Role
President, ImprimisRx
Signature
/s/ John P. Saharek
Stock symbol
HROW
Transactions as of
Feb 19, 2022
Transactions value $
-$204,014
Form type
4
Date filed
2/23/2022, 05:00 PM
Previous filing
Jul 23, 2021
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HROW Common Stock Options Exercise +50K +166.67% 80K Feb 19, 2022 Direct F1
transaction HROW Common Stock Tax liability -$204K -25.9K -32.4% $7.87 54.1K Feb 19, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HROW Restricted Stock Unit Options Exercise $0 -50K -100% $0.00* 0 Feb 19, 2022 Common Stock 50K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted to Mr. Saharek under the Issuer's 2017 Stock Incentive and Awards Plan on February 19, 2019. The RSUs settled in one share of common stock for each RSU and vested in full on February 19, 2022, the third anniversary of the grant date. 25,923 shares of common stock were withheld from issuance to Mr. Saharek for payroll tax purposes.